Immucell (ICCC) Net Cash Flow Growth (1y) (2011 - 2025)
Powered by 
Analysis
Immucell (ICCC) Net Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 73.93% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -167.84% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 272.00% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -6.86% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -296.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -57.47% |
| Sep 30, 2025 | -185.02% |
| Jun 30, 2025 | 284.44% |
| Mar 31, 2025 | 4,672.90% |
| Dec 31, 2024 | 95.01% |
| Sep 30, 2024 | 364.23% |
| Jun 30, 2024 | 122.17% |
| Mar 31, 2024 | 99.32% |
| Dec 31, 2023 | 66.71% |
| Sep 30, 2023 | 124.16% |
| Jun 30, 2023 | -112.14% |
| Mar 31, 2023 | -265.20% |
| Dec 31, 2022 | -878.50% |
| Sep 30, 2022 | -981.81% |
| Jun 30, 2022 | -119.87% |
| Mar 31, 2022 | 1,238.74% |
| Dec 31, 2021 | -119.04% |
| Sep 30, 2021 | 91.03% |
| Jun 30, 2021 | 1,391.17% |
| Mar 31, 2021 | -108.89% |